How to Develop and Maintain a Hazardous Drug List

Author(s):  Dillon L Rad

Issue:  May/Jun 2019 - Volume 23, Number 3
View All Articles in Issue

Abstract:  United States Pharmacopeia Chapter <800>, concerned with the handling of hazardous drugs in healthcare settings, requires that any entity handling such drugs maintain a hazardous drug list. While this list must include any drug found on the latest NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, entities are expected to include other drugs and substances of concern. This article provides guidance on the creation and maintenance of such a list.

Related Keywords: L. Rad Dillon, RPh, MA, ASQ CMQ/OE, ASQ CQA, ACHC.PCAB CAC, CAC, AQ SSGB, United States Pharmacopeia Chapter <800> Hazardous Drugs - Handling in Healthcare Settings, Hazard Communication Standard, Occupational Safety and Health Agency, OSHA, National Institute for Occupational Safety and Health, NIOSH, List of Antineoplastic and Other Hazardous Drugs, workplace safety, worker exposure, carcinogenicity, teratogenicity, reproductive toxicity, low dose organ toxicity, genotoxicity, Globally Harmonised System of Classification and Labelling of Chemicals, safety data sheets

Related Categories: LEGAL, SUPPORT, UNITED STATES PHARMACOPEIA CONVENTIONS, ADVERSE DRUG EVENTS, HAZARDOUS DRUGS

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=4602

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products